TSThany Seyok

Thany Seyok

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thany Seyok has a total of 35 co-authors. Here are the top co-authors by number of shared publications:

  • Brandon E. Earp

    Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    3 shared publications
  • Jamie E. Collins

    Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    3 shared publications
  • Samantha J. Erikson

    Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

    3 shared publications
  • Brittany Weber

    University of Texas Southwestern Medical Center

    2 shared publications
  • Elena Massarotti

    Division of Rheumatology, Inflammation, and Immunity Brigham and Women’s Hospital, Harvard Medical School Boston MA

    2 shared publications
  • Jorge Plutzky

    Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA

    2 shared publications

Latest Publications

  • Open Access

    Interplay Between Systemic Inflammation, Myocardial Injury, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis: Results From the LiiRA Study

    by Brittany Weber, Dana Weisenfeld, Elena Massarotti, Thany Seyok, Gabrielle Cremone, Ethan Lam, Charlotte Golnik, Seth Brownmiller, Feng Liu, Sicong Huang, et al.

    Background: Coronary microvascular dysfunction as measured by myocardial flow reserve (MFR) is associated with increased cardiovascular risk in rheumatoid arthritis (RA). The objective of this study was to determine the association between reducing inflammation with MFR and other measures of cardiovascular risk. Methods and Results: Patients with RA with active disease about to initiate a tumor necrosis factor inhibitor were enrolled (NCT02714881). All subjects underwent a cardiac perfusion positron emission tomography scan to quantify MFR at baseline before tumor necrosis factor inhibitor initiation, and after tumor necrosis factor inhibitor initiation at 24 weeks. MFR P =0.6) or hs‐cTnT. A correlation was observed between a reduction in hsCRP and interleukin‐1b with a reduction in hs‐cTnT. Conclusions: In this RA cohort with low prevalence of cardiovascular risk factors, nearly 50% of subjects had coronary microvascular dysfunction at baseline. A reduction in inflammation was not associated with improved MFR. However, a modest reduction in interleukin‐1b and no other inflammatory pathways was correlated with a reduction in subclinical myocardial injury. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02714881.


  • Open Access

    Factors Associated With Nonattendance for Osteoporosis Evaluation Following Fragility Fracture

    by Thany Seyok, Jamie E. Collins, Cole Hodys, Samantha J. Erikson, Samantha Perez Menendez, Brandon E. Earp, Julia F. Charles

    Introduction: This study assessed patient demographic factors associated with nonattendance for osteoporosis evaluation after being referred to our Bone Health Clinic (BHC), a hospital‐based outpatient Fracture Liaison Service (FLS), for a fragility fracture.Methods: 507 patients sustaining a fragility fracture were referred to the BHC over a 39‐month period. Retrospective chart review was conducted to capture osteoporosis evaluation attendance rates and demographic factors (age, gender, race, area deprivation index, insurance type, and fracture type). A post‐fracture follow‐up visit with either the BHC or another provider in which osteoporosis was noted in the assessment was considered attendance for osteoporosis evaluation. Nonattendance was determined at a cutoff of one year after the fracture date.Results: Of the 507 patients referred to the BHC following a fragility fracture, 177 patients attended osteoporosis evaluation with either the BHC or a primary care provider. Nonattendance was associated with older age (p = 0.0075), having private health insurance (p = 0.0434), and recent hip fracture (p < 0.0001). Attendance was associated with having government health insurance (p = 0.0103).Conclusion: Inpatient evaluation and treatment for osteoporosis should be considered in patients who are older or have sustained a hip fracture as they may have more difficulty attending post‐fracture appointments.


  • Impact of an Outpatient Fracture Liaison Service on Osteoporosis Evaluation Among Patients With Upper Extremity Fragility Fracture

    by Thany Seyok, Jamie E. Collins, Samantha J. Erikson, Julia F. Charles, Brandon E. Earp

    Background: The purpose of this study was to assess the impact of implementation of an outpatient fracture liaison service (FLS) on completion rates of dual-energy x-ray absorptiometry (DXA) and screening labs including 25-OH vitamin D and parathyroid hormone (PTH) in patients with upper extremity (UE) fragility fractures. Methods: At our institution, 367 patients were treated in 2014-2015 for UE fragility fractures of the distal radius and proximal humerus before implementation of our outpatient FLS and 395 patients in 2017-2018 after implementation. Retrospective chart review was conducted to identify completed DXA scans within 2 years of fracture treatment and completed 25-OH vitamin D and PTH labs within 1 year of fracture treatment. Results: There were no statistical differences in the demographics of patients treated for distal radial and proximal humeral fragility fractures during the 2014-2015 and 2017-2018 time periods. Implementation of the FLS resulted in a 9.9% increase ( P value = .021) in completed DXA scans within 2 years of fracture treatment. Completed 25-OH vitamin D and PTH labs saw a significant increase of 17.1% and 23.8%, respectively ( P values < .001). Conclusions: Implementation of an outpatient FLS can help to improve osteoporosis evaluation with completed DXA scans and 25-OH vitamin D and PTH labs.


  • Open Access

    Relationship Between Risk of Atherosclerotic Cardiovascular Disease, Inflammation, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis

    by Brittany Weber, Dana Weisenfeld, Thany Seyok, Sicong Huang, Elena Massarotti, Leanne Barrett, Courtney Bibbo, Daniel H. Solomon, Jorge Plutzky, Marcy Bolster, et al.


  • Future Fracture Risk in Upper Extremity Fracture and Non-Fracture Patients

    by Thany Seyok, Jamie E. Collins, Samantha J. Erikson, Julia F. Charles, Brandon E. Earp

    Background: Upper extremity (UE) fragility fractures are common and strong predictors of subsequent fractures. To investigate the relative importance of an UE fragility fracture in determining future fracture risk, we conducted a cross-sectional study to compare future fracture risk between patients presenting for osteoporosis evaluation after an UE fragility fracture and a similarly aged cohort of patients without an UE fracture. Methods: In all, 129 UE fracture patients seen in our bone health clinic (BHC) and 114 non-fracture UE fracture patients seen in an UE clinic completed clinic intake surveys assessing for fracture risk factors. Prefracture fracture risk (PFFR) and fracture risk assessment tool (FRAX) scores estimated the future fracture risks at the timepoint before and after the UE fragility fracture event, respectively. The primary study outcome was the 10-year risk of future fracture. Results: The 10-year probability of major osteoporotic and hip fractures were significantly higher among the BHC group when estimated with FRAX. When estimated with PFFR score, there was no difference in the 10-year probability of hip fracture between the groups. Prevalence of secondary osteoporosis and glucocorticoid use was higher in the BHC group, and prevalence of rheumatoid arthritis was higher in the UE clinic group. Conclusions: This study underscores the importance of an UE fragility fracture in determining the risk of future fracture. A fragility fracture of the UE should be considered a sentinel event and physicians who evaluate these patients should recognize them as a high-risk group for future hip fracture.